Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927833 · ClinicalTrials.gov registry record · NA
Cycled Phototherapy
A NA study of Premature Infant and Hyper Bilirubinemia, sponsored by NICHD Neonatal Research Network.
- Active
- Registry status
- NA
- Development phase
- 1,700
- Enrollment target
- 19
- Study locations
NCT03927833: Active NA study of Premature Infant and Hyper Bilirubinemia, sponsored by NICHD Neonatal Research Network.
NCT03927833 is a NA study of Premature Infant and Hyper Bilirubinemia that is active but no longer recruiting, run by NICHD Neonatal Research Network. The registered enrollment target is 1,700 participants, above the 101-participant average among 9 other Premature Infant trials with a reported enrollment target (1583% higher). The trial reports 19 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03927833, a NA study of Premature Infant and Hyper Bilirubinemia, is active but no longer recruiting, sponsored by NICHD Neonatal Research Network.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,700 participants
- Enrollment target
- 19
- Study locations
Study Summary
Cycled phototherapy (PT) is likely to increase survival over that with continuous PT among extremely premature infants (\< 750 g BW or \<27 weeks GA).
Primary Outcome
Number of Participants discharged from hospital alive, after birth.
Conditions Studied
Interventions
- DEVICE Phototherapy lights
Study Locations (19)
Ohio
- Cincinnati Children's Medical Center - Cincinnati
- Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland
- Research Institute at Nationwide Children's Hospital - Columbus
California
- Stanford University - Palo Alto
- Sharp Mary Birch Hospital for Women & Newborns - San Diego
North Carolina
- RTI International - Durham
- Duke University - Durham
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
- University of Texas Health Science Center at Houston - Houston
Alabama
- University of Alabama at Birmingham - Birmingham
Georgia
- Emory University - Atlanta
Illinois
- Northwestern Lurie Children's Hospital of Chicago - Chicago
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What the registry record for NCT03927833 still lists
NCT03927833 is an interventional study that assigns participants to a tested intervention. Its 1,700 participants enrollment target places it among the larger protocols in the corpus, above the 101-participant average among 9 other Premature Infant trials with a reported enrollment target (1583% higher).
The record links to 2 conditions, with Premature Infant appearing as the primary indexed condition, and to 1 intervention - of which Phototherapy lights is the first listed.
NCT03927833 lists 19 locations in 14 states (Ohio, California, North Carolina).
Frequently Asked Questions
What is clinical trial NCT03927833 about?
NCT03927833 is a clinical study titled "Cycled Phototherapy". Cycled phototherapy (PT) is likely to increase survival over that with continuous PT among extremely premature infants (\< 750 g BW or \<27 weeks GA).
What is the current status of trial NCT03927833?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,700 participants. The study started on 2020-07-16. Estimated completion is 2027-07-31.
What conditions does trial NCT03927833 study?
This clinical trial studies the following conditions: Premature Infant, Hyper Bilirubinemia.
What interventions are being tested in trial NCT03927833?
The interventions under investigation include: Phototherapy lights (DEVICE).
Who is sponsoring clinical trial NCT03927833?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03927833 being conducted?
This trial has 19 study locations across Alabama, California, Georgia, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Infant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03927833's enrollment target sits among peer trials
1,700 1st of 9 higher than 9 of 9 other Premature Infant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Infant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
RECRUITING · NA
-
Time to Accurate Heart Rate on Neonatal Outcomes
COMPLETED · NA
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
Growing Little PEAPODS Study
RECRUITING
-
Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
ACTIVE NOT RECRUITING
-
Ultrasound Assessment of BC in the NICU
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI